)
Shattuck Labs (STTK) investor relations material
Shattuck Labs Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual Meeting of Stockholders scheduled for May 28, 2026, to be held virtually at 11:30 AM Eastern Time.
Stockholders of record as of April 2, 2026, are eligible to participate and vote.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report, are available online or by request.
Voting matters and shareholder proposals
Election of three Class III director nominees to serve until the 2029 Annual Meeting: Taylor Schreiber, Helen M. Boudreau, and Clay Siegall.
Ratification of KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.
Advisory vote on the compensation of named executive officers (say-on-pay).
Advisory vote on the frequency of future say-on-pay votes.
Approval of an amendment and restatement of the 2020 Equity Incentive Plan.
Board of directors and corporate governance
Board recommends voting "FOR" each director nominee and all proposals except Proposal 4, where "1 YEAR" is recommended for the frequency of say-on-pay votes.
- Shareholders will vote on director elections, auditor ratification, executive pay, and equity plan changes.STTK
Proxy filing8 Apr 2026 - SL-325 offers a novel, potent approach to IBD by targeting DR3, with Phase 2 trials planned.STTK
Corporate presentation5 Mar 2026 - SL-325 clinical progress and a strengthened cash position extend operational runway into 2029.STTK
Q4 20255 Mar 2026 - DR3 antibody program targets superior efficacy and lower immunogenicity in IBD, with phase IIb trial soon.STTK
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - SL325, a DR3-targeting antibody, advances to clinical trials for IBD with IND planned mid-2025.STTK
Piper Sandler 36th Annual Healthcare Conference3 Feb 2026 - SL-172154 plus azacitidine achieved high response rates and manageable safety in HR-MDS and TP53 mutant AML.STTK
Study Update3 Feb 2026 - SL-172154 discontinued for marginal benefit; SL-325 DR3 antibody advances to phase I in 2026.STTK
Study Update20 Jan 2026 - Shelf registration allows up to $200M in securities for clinical and corporate growth amid notable risks.STTK
Registration Filing13 Jan 2026 - DR3 targeting may deliver more durable and effective IBD therapy, with clinical data expected in 2026.STTK
7th Annual Evercore ISI HealthCONx Healthcare Conference12 Jan 2026
Next Shattuck Labs earnings date
Next Shattuck Labs earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)